[Stereotactic body radiation radiotherapy for oligometastatic @entity1149 ( XXXX ): A case report].

@entity1 @entity75 @entity5 @entity1149 @entity2220
UNASSIGNED: Metastatic @entity1149 is associated with a poor prognosis, and palliative chemotherapy is the mainstay of treatment. However, long-time survival has been observed in oligometastatic @entity1 treated with locally ablative therapies to all sites of metastatic disease. An 80-year-old @entity1 was diagnosed with an @entity2220 . The right @entity75 was classified cT2aN0M0  and was treated with stereotactic body radiation therapy at the dose of 60Gy in eight fractions. A few months after, he successively presented with two brain metastases and one left adrenal metastasis, with a complete response on the @entity5 . The three secondary lesions were treated with stereotactic body radiation therapy alone. Thirty months after the diagnosis and 12months after metastases' apparition, primary and @entity75 kept controlled (complete response). Oligometastatic @entity1149 management is not clear. Locally ablative therapies such as stereotactic body radiation therapy, surgery and radiofrequency are efficient and should be considered. A phase III study should evaluate radical treatment strategies in such @entity1 .
